Bulletin
Investor Alert

New York Markets After Hours

Adverum Biotechnologies Inc.

NAS: ADVM

GO
/marketstate/country/us

After Hours

/zigman2/quotes/210484271/composite

$

10.81

Change

0.00 0.00%

Volume

Volume 380,481

Sep 25, 2020, 4:29 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/210484271/composite

Today's close

$ 10.50

$ 10.81

Change

+0.31 +2.95%

Day low

Day high

$10.43

$10.91

Open
Open: 10.43

52 week low

52 week high

$4.96

$26.98

Open

Market cap

$999.14M

Average volume

1.40M

P/E ratio

N/A

Rev. per Employee

$19,659

EPS

-1.22

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/advm

MarketWatch News on ADVM

  1. Adverum Biotechnologies downgraded to umderperform from market perform at Raymond James

    5:52 p.m. June 26, 2020

    - Tomi Kilgore

  2. Adverum Biotechnologies upgraded to buy from hold at SunTrust RH

    7:19 a.m. May 5, 2020

    - Tomi Kilgore

  3. Our Roundtable Experts Pick 14 Biotech Stocks

    6:10 p.m. Oct. 2, 2019

    - Barron's Online

  4. The stock market will keep charging ahead

    1:22 p.m. July 12, 2019

    - Lawrence G. McMillan

  5. Blackstone’s Interest in Oil

    6:01 a.m. May 18, 2019

    - Barron's Online

  6. Adverum Biotechnologies started at buy with $11 stock price target at SunTrust RH

    7:54 a.m. Aug. 30, 2018

    - Tomi Kilgore

  7. Adage Capital: Three Stocks It’s Buying

    10:42 a.m. Dec. 26, 2017

    - Barron's Online

  8. The Time Has Come: 4 Gene Therapy Stocks to Buy, 1 to Avoid

    2:35 p.m. Oct. 12, 2017

    - Barrons Blogs

  9. Biogen’s Billion-Dollar Bet on Gene Therapy

    10:55 a.m. July 7, 2015

    - Barron's Online

  10. Biogen: Where Did That Come From?

    3:30 p.m. July 2, 2015

    - Barrons Blogs

  11. Charting the Market

    12:19 a.m. June 20, 2015

    - Barron's Online

  12. Smith & Wesson shares drop after hours on weak outlook

    5:24 p.m. June 18, 2015

    - Sue Chang

  13. Adobe shares slide after hours on weak outlook

    4:59 p.m. June 16, 2015

    - Sue Chang

  14. Why Avalanche’s Disappointing Trial is Good News for Regeneron

    11:09 a.m. June 16, 2015

    - Barrons Blogs

  15. Avalanche Biotechnologies falls 49% in early action

    9:30 a.m. June 16, 2015

    - MarketWatch

  16. Regeneron: Why It’s Heading to $550

    11:33 a.m. May 18, 2015

    - Barrons Blogs

  17. Loading more headlines...
/news/nonmarketwatch/company/us/advm

Other News on ADVM

  1. New Strong Sell Stocks for September 8th

    8:57 a.m. Sept. 8, 2020

    - Zacks.com

  2. Graybug Vision readies IPO

    3:33 p.m. Sept. 5, 2020

    - Seeking Alpha

  3. Adverum (ADVM) Surges: Stock Moves 6.2% Higher

    8:51 a.m. Aug. 17, 2020

    - Zacks.com

  4. RVLV, GRWG, ADVM and VREX among midday movers

    12:39 p.m. Aug. 13, 2020

    - Seeking Alpha

  5. VRM, CSCO among premarket losers

    8:18 a.m. Aug. 13, 2020

    - Seeking Alpha

  6. Adverum's gene therapy shows encouraging action in wet AMD study

    12:54 p.m. Aug. 11, 2020

    - Seeking Alpha

  7. Timing the Market, Is it Possible? - June 26, 2020

    10:29 a.m. June 26, 2020

    - Zacks.com

  8. FDA rejects Allergan application for wet AMD drug

    6:33 a.m. June 26, 2020

    - Seeking Alpha

  9. Loading more headlines...
/news/pressrelease/company/us/advm

Press Releases on ADVM

  1. Nkarta Reports Second Quarter 2020 Financial Results

    4:38 p.m. Aug. 20, 2020

    - GlobeNewswire

  2. Macular Edema Therapeutics Market Global Research and analysis 2020 to 2026

    5:11 a.m. Aug. 20, 2020

    - Market Insight Reports

  3. RSI Signals Bullish Stocks: $XXII $OSPN $ADVM

    10:07 a.m. Aug. 14, 2020

    - The Market Signal

  4. Loading more headlines...

Rates »

Link to MarketWatch's Slice.